The role of oncolytic viruses in immuno-oncology
Interviewee/Contributor
Bernard Huber and Paul Higham
Organisation
Oryx GmbH & Co KG and Valo Therapeutics Ltd
Drug discovery
Investors support new antifungal agent
Interviewee/Contributor
Ralf Schmid and Emma Harvey
Organisation
F2G Ltd
Evox developes exosomes as therapeutics
Interviewee/Contributor
Antonin de Fougerolles
Organisation
Evox Therapeutics Ltd
Unlocking the potential of PSMA as a cancer target
Interviewee/Contributor
Brian McGuinness and Theodora Harold
Organisation
Crescendo Biologics Ltd
Convalescent plasma hope in SARS-CoV-2 crisis
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
What patients really want: involvement
Interviewee/Contributor
Pierre Meulien
Organisation
Innovative Medicines Initiative
A meeting of minds at AstraZeneca
Interviewee/Contributor
José Baselga
Organisation
AstraZeneca Plc
Interview: The metabolic route to drug discovery
Interviewee/Contributor
David Moller
Organisation
Poxel SA
Interview: Targeting diseases of cortisol deficiency
Interviewee/Contributor
Martin Whitaker
Organisation
Diurnal Group Plc
The changing landscape for haemophilia treatment
Interviewee/Contributor
Victoria English
Organisation
MedNous